Skip to main content

Table 1 Circulating concentrations (mean ± SD) of measured parameters in patients with dengue serotype-2 virus infection during the febrile stage, defervescence and convalescence (N = 15), in healthy controls (N = 20) and in non-dengue febrile controls (N = 15)

From: Augmentation of 5-lipoxygenase activity and expression during dengue serotype-2 infection

Parameters

Febrile

Defervescence

Convalescence

Healthy controls

Non-dengue febrile controls

Plasma LTB4 (p mol/μmol AA)

0.35 (0.35)b

0.38 (0.34)b

0.01 (0.02)c

0.01 (0.01)c

0.17 (0.12)d

Serum hsCRP (mg/L)

6.10 (6.70)b

3.30 (3.00)b

0.60 (1.50)c

1.02 (1.01)c

3.36 (3.69)b

Plasma arachidonic acid (μg/mL)

89.0 (26.4)a

95.8 (24.3)a

110.0 (20.2)a

86.5 (19.7)a

87.7 (22.5)a

Plasma phospholipase A2 activity (nmol/ min/mL)

4.3 (0.9)a

4.4 (1.0)a

4.2 (0.9)a

4.2 (1.1)a

-

  1. Data are summarized as mean (standard deviation).
  2. aNormally distributed data with the same subscripts are not significantly different with each other using one-way ANOVA analyses with Bonferroni adjustment.
  3. b,c,dNon-parametric data with the same subscripts are not significantly different with each other using Kruskal-Wallis analysis with Dunn’s adjustment.